Cancer gene discovery using somatic transposon mutagenesis in the mouse and systems for validation of identified candidate cancer genes and pathways.

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Cancer gene discovery using somatic transposon mutagenesis in the mouse and systems for validation of identified candidate cancer genes and pathways.

Published Date

2012-07

Publisher

Type

Thesis or Dissertation

Abstract

The conditional Sleeping Beauty (SB) transposon mutagenesis system has proven to be a successful method for cancer gene identification in solid tumors. Using tissue specific Cre recombinases (TSP-Cre) to selectively activate SB mediated mutagenesis in tissues of interest has yielded numerous novel candidate cancer genes in leukemia/lymphoma, colorectal, liver, and pancreatic cancers. We implemented the SB system for the identification of genes involved in osteosarcoma (OS). OS is the most common cancer of the bone and third most common cancer in children and adolescents. The 5-year survival rate of OS patients is 60-70%, though with metastatic disease it drops to less than 20%-30%. Identification of genes responsible for OS development and metastasis has been difficult due to its genomic instability and subsequent complexity. Consequently, there is a pressing need to identify the genes and pathways governing OS development and metastasis. To this end, we performed a forward genetic screen utilizing the conditional Sleeping Beauty (SB) transposase and mutagenic T2/Onc transposon system in Osx-Cre mice on a predisposing Trp53LSL-R270H/+ or wild type background to induce random somatic mutations that induce OS development and metastasis. One hundred and nineteen OSs were isolated from 96 predisposed and 20 wild type mice undergoing SB mutagenesis, with a subset of animals harboring metastases to the liver and/or lungs. Over 100 candidate cancer genes, both known and novel, were identified by analysis of recurrent T2/Onc insertion sites. In order to validate the candidate cancer genes identified in our screen, we developed a recombinase-based system for efficient assembly of vectors to over express or knock down 1-6 genes in mammalian cells. Further, these vectors were constructed in Piggybac transposons to allow for stable and reversible integration of the vector via transposition. In addition to cDNA over expression or shRNA knock down, we also developed methods for generation and selection of candidate cancer gene knock out cell lines using TAL effector nucleases (TALENs).

Description

University of Minnesota Ph.D. dissertation. July 2012. Major: Molecular, Cellular, Developmental Biology and Genetics. Advisor: David A. Largaespada. 1 computer file (PDF); xiii, 239 pages.

Related to

Replaces

License

Collections

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Suggested citation

Moriarity, Branden Scott. (2012). Cancer gene discovery using somatic transposon mutagenesis in the mouse and systems for validation of identified candidate cancer genes and pathways.. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/134503.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.